(Q37439075)

English

Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience

scientific article published on 17 October 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

0 references

1 reference

based on heuristic

inferred from title

phaeochromocytoma

1 reference

based on heuristic

inferred from title

author name string

Montserrat Ayala-Ramirez

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Lei Feng

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Mouhammed A Habra

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Thereasa Rich

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Paxton V Dickson

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Nancy Perrier

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Alexandria Phan

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Steven Waguespack

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Shreyaskumar Patel

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Camilo Jimenez

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

17 October 2011

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

118

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

2804-2812

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

describes a project that uses

1 reference

Europe PubMed Central

26 June 2022

https://europepmc.org/article/PMC/PMC3882190

based on heuristic

inferred from PubMed Central ID database lookup

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

Colorectal cancer liver metastases - understanding the differences in the management of synchronous and metachronous disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

The diagnosis and management of malignant phaeochromocytoma and paraganglioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

Biochemical diagnosis of pheochromocytoma: which test is best?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

National Cancer Data Base report on malignant paragangliomas of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

Blood pressure, stroke, and coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

23 August 2017

Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

14 September 2017

Pheochromocytoma in Italy: a multicentric retrospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

26 June 2018

Analysis of survival by tumor response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

26 June 2018

Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

26 June 2018

One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976: a clinicopathological analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

26 June 2018

Pulmonary metastases in children with osteosarcoma: characteristics and impact on patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882190

2 September 2018

Malignant phaeochromocytoma of the organ of Zuckerkandl with functioning metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22006217

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of malignant pheochromocytoma with combination chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22006217

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 15-year experience with chemotherapy of patients with paraganglioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22006217

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables

1 reference

https://pubmed.ncbi.nlm.nih.gov/22006217

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CNCR.26577

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

release_kys4vvlrlrgsldc365rllomatq

1 reference

https://api.fatcat.wiki/v0/release/kys4vvlrlrgsldc365rllomatq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37439075&oldid=2127235708"